ClinicalTrials.gg
CompletedNCT03295994ARCUpdated Nov 19, 2026Results posted

Operative Versus Non-Operative Treatment for Atraumatic Rotator Cuff Tears

An interventional study of Arthroscopic Rotator Cuff Surgery and Physical Therapy in Rotator Cuff Tear and Physical Medicine and Rehabilitation, sponsored by University of Michigan. Completed at 19 sites in United States. Open to participants aged 40 Years to 84 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

How we know

Updated Nov 19, 2026Results postedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
187
Allocation
Randomized
Ages
40 Years to 84 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 168 studies in Rotator Cuff Injuries with a site in United States — 40 open to participants now, 50 under way, none of them phase 3. Rotator Cuff Injuries · United States.

Enrollment
13th of 130
187 · median 60
Started
2018
with 12 others
No phase
86 of 168
21 open now
Registered
51st of 168
by date

Among the 168 studies in Rotator Cuff Injuries with a site in United States, this one is the 13th largest by enrollment of the 130 interventional ones that give a count, is one of 13 that started in 2018, is one of 86 with no phase, and was the 51st registered.

Rotator Cuff Injuries

632 studies on the registry are indexed under Rotator Cuff Injuries; 157 are open to participants now.

Browse Rotator Cuff Injuries studies →

Open to participants now

40 of the 168 studies in Rotator Cuff Injuries with a site in United States are open now. Recruiting first, the newest first:

35 more — sign in →

All 40 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.

This study: 40 Years to 84 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 168 studies in Rotator Cuff Injuries with a site in United States, or all of them as a file.
02

Study summary

Rotator cuff tears are one of the most common reasons to seek musculoskeletal care in the United States and one of the fastest growing ambulatory surgery procedures. However, data on comparison of operative versus non-operative treatment is lacking and urgently needed.

Read the detailed description

This is non-blinded, randomized controlled trial. Participants will be randomly assigned to either an operative or non-operative course of treatment and will be followed for 12 months from baseline.

Aim 1: To compare pain and function in patients undergoing operative versus non-operative treatment of atraumatic rotator cuff tears at 12 months of follow-up

Aim 2: To assess effects of rotator cuff tear size and age on comparative outcomes of operative versus non-operative treatments for atraumatic rotator cuff tears

5U34AR069201-02 NIH grant funded the preparatory work for the trial but not the trial itself.

03

Conditions studied

  • Rotator Cuff Tear
  • Physical Medicine and Rehabilitation

Browse trials for

Keywords

  • arthroscopy
  • physical therapy
  • rehabilitation
  • surgery
  • rotator cuff tear
04

Who can participate

Ages eligible
40 Years to 84 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged =>40 years to \<85 years
  • Shoulder pain and/or loss of range of active motion, strength or function
  • MRI-confirmed partial- or full-thickness supraspinatus and/or infraspinatus tear of 4cm or less in longitudinal dimension
  • Medically fit for surgery, defined as Category I-III per (ASA) Physical Status Classification
  • Ability and willingness to provide

Exclusion criteria

Exclusion Criteria:

  • Primary diagnosis is something other than a rotator cuff tear
  • History (in last 2 years) of shoulder fracture involving the humeral head on affected side
  • Previous rotator cuff surgery on affected side
  • Isolated subscapularis \&/or teres minor tear on affected side
  • Acute rotator cuff tear caused by a severe trauma
  • Shoulder used as a weight-bearing joint
  • to MRI (claustrophobia, pacemaker, pregnancy, shoulder implant, etc.)
  • Glenohumeral osteoarthritis on xrays/MRI, as determined by recruiting MD
  • Grade 4 fatty infiltration of rotator cuff (any tendons)
  • Candidate for shoulder arthroplasty at baseline
  • Non-English speaking
  • Severe problems with maintaining follow-up expected (such as, but not limited to, history of substance abuse, homelessness/incarceration, dementia, brain injury, and psychotic disorders)
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
187 participants (actual)

Study arms

  • Active comparator
    Operative

    surgery + post-operative physical therapy

    Procedure: Arthroscopic Rotator Cuff Surgery · Procedure: Physical Therapy

  • Active comparator
    Non-Operative

    non-operative physical therapy

    Procedure: Physical Therapy

Interventions

  • ProcedureArthroscopic Rotator Cuff Surgery

    Arthroscopic rotator cuff surgery

  • ProcedurePhysical Therapy

    Physical therapy

06

What researchers measure

Primary outcomes

  1. Shoulder Pain & Disability Index (SPADI)

    SPADI is a composite pain and function measure. The scale range is from 0 to 100, with 0 being best, and 100 being worst.

    Time frame: Study participants completed the Shoulder Pain and Disability Index (SPADI) at baseline and at 3, 6, and 12 months after baseline.

Secondary outcomes

  1. American Shoulder and Elbow Surgeons (ASES)

    ASES is a pain and activity of daily living questionnaire. The range is from 0 to 100, with 0 being worst, and 100 being best.

    Time frame: Study participants completed the American Shoulder and Elbow Surgeons (ASES) at baseline and at 3, 6, and 12 months after baseline.

07

Results

Posted Nov 19, 2026

Participant flow

Participant flow — Overall Study
MilestoneOperativeNon-Operative
Started9988
Completed8375
Not completed1613
Withdrew: Withdrawal by subject72
Withdrew: Terminated14
Withdrew: Lost to follow-up87

Outcome measures

PrimaryShoulder Pain & Disability Index (SPADI)

SPADI is a composite pain and function measure. The scale range is from 0 to 100, with 0 being best, and 100 being worst.

Time frame:
Study participants completed the Shoulder Pain and Disability Index (SPADI) at baseline and at 3, 6, and 12 months after baseline.
Reported as:
Mean · score on a scale
Shoulder Pain & Disability Index (SPADI)
score on a scaleOperativeNon-Operative
Baseline51.33 ± 22.253.1 ± 22.73
3 months49.56 ± 25.532.68 ± 27.64
6 months32.18 ± 28.0930.04 ± 27.62
12 months16.9 ± 23.0722.73 ± 24.6
Statistical analysis
  • Operative vs Non-Operative · Longitudinal mixed-effects model · p = 0.115 (Hypothesis testing was based on fixed-effect estimates from the longitudinal mixed-effects model. A significant treatment-by-time interaction indicates differential change in SPADI scores over follow-up between treatment groups.) · Estimated mean differences: -6.33 · 95% CI -14.20 to 1.54The estimates represent the adjusted intention-to-treat (ITT) model.
SecondaryAmerican Shoulder and Elbow Surgeons (ASES)

ASES is a pain and activity of daily living questionnaire. The range is from 0 to 100, with 0 being worst, and 100 being best.

Time frame:
Study participants completed the American Shoulder and Elbow Surgeons (ASES) at baseline and at 3, 6, and 12 months after baseline.
Reported as:
Mean · score on a scale
American Shoulder and Elbow Surgeons (ASES)
score on a scaleOperativeNon-Operative
Baseline48.47 ± 22.0649.1 ± 19.9
3 Months48.17 ± 22.9830.11 ± 21.07
6 Months31.86 ± 23.6827.4 ± 22.31
12 Months19.14 ± 22.0722.10 ± 20.93
Statistical analysis
  • Operative vs Non-Operative · Longitudinal mixed-effects model · p = 0.524 (Hypothesis testing was based on fixed-effect estimates from the mixed-effects model, including treatment, time, and treatment-by-time interaction.) · Estimated mean differences: -2.79 · 95% CI -11.39 to 5.81The estimates represent the adjusted intention-to-treat (ITT) model.

Adverse events

Collected over 12 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Operative0/99 (0%)3/99 (3%)9/99 (9.1%)
Non-Operative0/88 (0%)1/88 (1.1%)1/88 (1.1%)
Most frequent serious events
Most frequent serious events
EventOperativeNon-Operative
Event requiring hospitalizationGeneral disorders3/991/88
Most frequent other events
Most frequent other events
EventOperativeNon-Operative
Adhesive capsulitis (frozen shoulder)Surgical and medical procedures3/990/88
OtherGeneral disorders2/990/88
Complications from anesthesiaGeneral disorders2/990/88
Nerve injuryNervous system disorders1/991/88
Post-op bleedingBlood and lymphatic system disorders1/990/88

Baseline characteristics

Age, Continuous
Age, Continuous(Years)OperativeNon-OperativeTotal
Mean62.2 ± 8.0563.3 ± 7.7462.7 ± 7.91
Sex: Female, Male
Sex: Female, Male(Participants)OperativeNon-OperativeTotal
Female5657113
Male433174
Race (NIH/OMB)
Race (NIH/OMB)(Participants)OperativeNon-OperativeTotal
American Indian or Alaska Native202
Asian112
Native Hawaiian or Other Pacific Islander000
Black or African American201434
White6870138
More than one race617
Unknown or Not Reported224
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)OperativeNon-OperativeTotal
Hispanic or Latino8311
Not Hispanic or Latino9185176
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)OperativeNon-OperativeTotal
United States9988187
08

Study locations

19 sites
  • Mayo Clinic
    Phoenix, Arizona 85054, United States
  • University of California - San Francisco (UCSF)
    San Francisco, California 94158, United States
  • Western Orthopaedics
    Denver, Colorado 80218, United States
  • University of Colorado - Denver
    Denver, Colorado 80222, United States
  • University of Iowa
    Iowa City, Iowa 52242, United States
  • University of Kentucky
    Lexington, Kentucky 40536, United States
  • Johns Hopkins
    Baltimore, Maryland 21218, United States
  • Boston Medical Center
    Boston, Massachusetts 02118, United States
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215, United States
  • University of Michigan
    Ann Arbor, Michigan 48106, United States
  • Washington University
    St Louis, Missouri 63110, United States
  • The Ohio State University Wexner Medical Center
    Columbus, Ohio 43202, United States
  • University of Pennsylvania
    Philadelphia, Pennsylvania 19104, United States
  • Medical University of South Carolina
    Charleston, South Carolina 29425, United States
  • Orthopedic Institute
    Sioux Falls, South Dakota 57105, United States
  • Ortho Tennessee - Knoxville Orthopedic Clinic
    Knoxville, Tennessee 37922, United States
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37232, United States
  • University of Texas Southwestern
    Dallas, Texas 75390, United States
  • Ortho Virginia
    Richmond, Virginia 23294, United States
09

References and documents

Publications

  • Jain NB, Ayers GD, Koudelkova H, Archer KR, Dickinson R, Richardson B, Derryberry M, Kuhn JE; ARC Trial Group. Operative vs Nonoperative Treatment for Atraumatic Rotator Cuff Tears: A Trial Protocol for the Arthroscopic Rotator Cuff Pragmatic Randomized Clinical Trial. JAMA Netw Open. 2019 Aug 2;2(8):e199050. doi: 10.1001/jamanetworkopen.2019.9050. PubMed 31397866 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2018 to primary completion in Feb 2025, 83 months.

Results were first posted in Nov 2026, 1 year 8 months after primary completion. A results delay was requested in Feb 2026.

Of 228 non-industry interventional studies with no phase under Rotator Cuff Injuries, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's 83 months is above that.

Counting every sponsor, half of 252 studies reached it within 23 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2017
First posted
Sep 28, 2017
StartActual
Mar 19, 2018
Primary completionActual
Feb 28, 2025
CompletionActual
Feb 28, 2025
Results delay requested
Feb 5, 2026
Results first posted
Nov 19, 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 19, 2026
Primary outcomes
1 time frame changed
What changed in the outcomes
  • Time frameShoulder Pain & Disability Index (SPADI)Study participants will be followed for 12 months → Study participants completed the Shoulder Pain and Disability Index (SPADI) at baseline and at 3, 6, and 12 months after baseline.
Nov 19, 2026
Secondary outcomes
1 time frame changed
What changed in the outcomes
  • Time frameAmerican Shoulder and Elbow Surgeons (ASES)Study participants will be followed for 12 months → Study participants completed the American Shoulder and Elbow Surgeons (ASES) at baseline and at 3, 6, and 12 months after baseline.
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Results posted
    Primary outcomes 1 time frame changed
    What changed in the outcomes
    • Time frameShoulder Pain & Disability Index (SPADI)Study participants will be followed for 12 months → Study participants completed the Shoulder Pain and Disability Index (SPADI) at baseline and at 3, 6, and 12 months after baseline.
    Secondary outcomes 1 time frame changed
    What changed in the outcomes
    • Time frameAmerican Shoulder and Elbow Surgeons (ASES)Study participants will be followed for 12 months → Study participants completed the American Shoulder and Elbow Surgeons (ASES) at baseline and at 3, 6, and 12 months after baseline.
    + 4 other changes: verification date, responsible party, description and conditions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT03295994
Collaborators
Patient-Centered Outcomes Research Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Responsible party
Nitin Jain (Professor of Physical Medicine & Rehabilitation, University of Michigan) — Principal investigator
First posted
Sep 28, 2017
Start date
Mar 19, 2018
Primary completion
Feb 28, 2025
Completion
Feb 28, 2025
Results posted
Nov 19, 2026
Last update
Nov 19, 2026

Study contacts

Nitin B Jain, MD,MSPH
principal investigator · University of Michigan

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion